Abstract
Purpose
To evaluate the sensitivity and specificity of the DNA chip method in diagnosing patients with granular corneal dystrophy type II (GCD II) induced by mutation of the β igh3 gene.
Methods
Two hundred twenty-seven patients who visited Severance Eye hospital, corneal dystrophy clinic, from 1 July 2006 to 30 September 2007 were included in this study after history taking and review of their medical records. All subjects were examined by slit lamp microscopy, and blood sampling was done. The sampled blood was used in DNA sequencing and the DNA chip method.
Results
Among 227 subjects, 125 (54.6%) patients had GCD II and 103 (45.4%) patients showed normal results according to the DNA sequencing method. The sensitivity and specificity of the DNA chip method were both 100%, while the sensitivity of the slit lamp method was 99.19% and the specificity was 100%.
References
1. Afshari NA, Mullally JE, Afshari MA. . Survey of patients with granular, lattice, avellino, and Reis-Bucklers corneal dystrophies for mutations in the BIGH3 and gelsolin genes. Arch Ophthalmol. 2001; 119:16–22.
2. Chau HM, Ha NT, Cung LX. . H626R and R124C mutations of the TGFBI (BIGH3) gene caused lattice corneal dystrophy in Vietnamese people. Br J Ophthalmol. 2003; 87:686–9.
3. Ellies P, Renard G, Valleix S. . Clinical outcome of eight BIGH3-linked corneal dystrophies. Ophthalmology. 2002; 109:793–7.
4. Hellenbroich Y, Tzivras G, Neppert B. . R124C mutation of the ßIGH3 gene leads to remarkable phenotypic variability in a Greek four-generation family with lattice corneal dystrophy type 1. Ophthalmologica. 2001; 215:444–7.
5. Schmitt-Bernard CF, Chavanieu A, Derancourt J. . In vitro creation of amyloid fibrils from native and Arg124Cys mutated betaIGH3((110-131)) peptides, and its relevance for lattice corneal amyloid dystrophy type I. Biochem Biophys Res Commun. 2000; 273:649–53.
6. Ferry AP, Benson WH, Weinberg RS. Combined granularlattice (Avellino) corneal dystrophy. Trans Am Ophthalmol Soc. 1997; 95:61–77.
7. Moon JW, Kim SW, Kim TI. . Homozygous granular corneal dystrophy type II (Avellino corneal dystrophy) natural history and progression after treatment. Cornea. 2007; 26:1095–100.
8. Holland EJ, Daya SM, Stone EM. . Avellino corneal dystrophy: clinical manifestations and natural history. Ophthalmology. 1992; 99:1564–8.
9. Jun RM, Tchah H, Kim TI. . Avellino corneal dystrophy after LASIK. Ophthalmology. 2004; 111:463–8.
10. Wan XH, Lee HC, Stulting RD. . Exacerbation of Avellino corneal dystrophy after laser in situ keratomileusis. Cornea. 2002; 21:223–6.
11. Roh MI, Grossniklaus HE, Chung SH. . Avellino corneal dystrophy exacerbated after LASIK scanning electron microscopic findings. Cornea. 2006; 25:306–11.
12. Banning CS, Kim WC, Randleman JB. . Exacerbation of Avellino corneal dystrophy after LASIK in north America. Cornea. 2006; 25:482–4.
13. Wan XH, Lee HC, Stulting RD. . Exacerbation of Avellino corneal dystrophy after laser in situ keratomileusis. Cornea. 2002; 21:223–6.
14. El-Ashry MF, Abd El-Aziz MM, Ficker LA. . BIGH3 mutation in a Bangladeshi family with a variable phenotype of LCDI. Eye. 2004; 18:723–8.
15. Konishi M, Yamada M, Nakamura Y, Mashima Y. Varied appearance of cornea of patients with corneal dystrophy associated with R124H mutation in the BIGH3 gene. Cornea. 1999; 18:424–9.
16. Yoshida S, Yoshida A, Nakao S. . Lattice corneal dystrophy type I without typical lattice lines: role of mutational analysis. Am J Ophthalmol. 2004; 137:586–8.
17. Mitterer G, Huber M, Leidinger E. . Microarray-based identification of bacteria in clinical samples by solid-phase PCR amplification of 23S ribosomal DNA sequences. J Clin Microbiol. 2004; 42:1048–57.
18. Siemering K, Manji SS, Hutchison WM. . Detection of mutations in genes associated with hearing loss using a microarray-based approach. J Mol Diagn. 2006; 8:483–9.
19. Yoo SY, Kim TI, Lee SY. . Development of a DNA chip for the diagnosis of the most common corneal dystrophies caused by mutations in the betaigh3 gene. Br J Ophthalmol. 2007; 91:722–7.
20. Yamamoto S, Okada M, Tsujikawa M. . The spectrum of beta ig-h3 gene mutations in Japanese patients with corneal dystrophy. Cornea. 2000; May. 19:S21–3.
tables
Table 1.
Cornea dystrophy N (%) | Normal N (%) | Total N (%) | |
---|---|---|---|
Sex | |||
Male | 40 (32.26) | 43 (41.75) | 83 (36.56) |
Female | 84 (67.74) | 60 (58.25) | 144 (63.44) |
Age | |||
-10 | 4 (3.23) | 2 (1.94) | 6 (2.64) |
11-20 | 12 (9.68) | 11 (10.68) | 23 (10.13) |
21-30 | 34 (27.42) | 21 (20.39) | 55 (24.23) |
31-40 | 20 (16.13) | 24 (23.30) | 44 (19.38) |
41-50 | 18 (14.52) | 19 (18.45) | 37 (16.30) |
51-60 | 21 (16.94) | 16 (15.53) | 37 (16.30) |
60-70 | 10 (8.06) | 6 (5.83) | 16 (7.05) |
71-80 | 4 (3.23) | 3 (2.91) | 7 (3.08) |
80- | 1 (0.81) | 1 (0.97) | 2 (0.88) |
Mean±SD | 37.78±17.12 | 38.08±16.03 | 37.92±16.60 |
Systemic disease* | |||
More than one | 24 (19.35) | 15 (14.56) | 39 (17.18) |
None | 100 (80.65) | 88 (85.44) | 188 (82.82) |
Total | 124 (54.63) | 103 (45.37) | 227 (100.00) |
Table 2.
Dignosed by slit lamp† | |||||
---|---|---|---|---|---|
|
|||||
Normal | ACD‡, heterozygote | ACD, homozygote | Total | Sensitivity of slit lamp method (%) | |
Diagnosis* | |||||
Normal | 103 | 0 | 0 | 103 | |
ACD, heterozygote ACD, homozygote | 10 | 119 0 | 0 4 | 120 4 | 99.19 |
Total | 104 | 119 | 4 | 227 | |
Specificity of slit lamp method (%) | 100.0 |